Anthos Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201901345 · Approved 2019.03.06
This product's status changed to Expired on 2024.03.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of Type 2 Diabetes (Blood Sugar Control)
This medication is used to enhance blood sugar control in patients with type 2 diabetes when combined with diet and exercise. It can also be used as monotherapy, and if there is insufficient blood sugar improvement after using other oral hypoglycemic agents, it can be administered in combination with sulfonylureas, metformin, or insulin. Additionally, it is important for patients with type 2 diabetes to engage in nutritional counseling, weight loss, and exercise programs, as these lifestyle modifications significantly help maintain the effectiveness of medication therapy as well as initial treatment. This medication improves blood sugar control in patients with type 2 diabetes.
This medication is administered orally once daily, regardless of meals. As monotherapy, treatment can begin with a dose of 15 mg once daily, and the dose may be escalated to 30 mg once daily if insufficient efficacy is observed. For combination therapy, a dose of 15 mg once daily is also administered, with a maximum recommended dose of 30 mg once daily.
Use is not recommended due to lack of experience in patients under 18 years old.
This medication helps control blood sugar in patients with type 2 diabetes. When taking this medicine, attention should be paid to heart function. It should not be administered to patients with heart disease known as congestive heart failure or a history of this condition. This medication may cause fluid retention, which can worsen heart failure. Signs of heart failure include sudden weight gain, shortness of breath, and swelling. If any of these symptoms occur, consult a physician immediately. Additionally, this medication should not be used in patients with bladder cancer or a history of bladder cancer. If symptoms such as urination difficulties or hematuria occur, notify a healthcare provider immediately. Patients with poor liver function or severely impaired kidney function should not use this medication. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women should use appropriate contraception as this medication may stimulate ovulation. When this medication is used in combination with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, so dosage adjustments may be needed under a physician's guidance. Regularly monitor blood sugar and liver function tests during treatment, and carefully observe for signs of weight gain or swelling. This medication should be taken once daily, regardless of meals, and if a dose is missed, do not take double the dose the next day. An overdose may not show specific symptoms, but it is important to consult a healthcare provider for appropriate treatment immediately. It is not recommended for use in children or patients under 18 as safety and efficacy have not been established. Special caution is also required for the elderly, especially those over 75 years old who should use this medication with care. Store this medication out of reach of children, and it is safer to keep it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperature between 1 and 30 degrees Celsius at room temperature.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.